Pyogenic Liver Abcess in Guadeloupe
PYG
1 other identifier
observational
58
1 country
1
Brief Summary
Liver abscesses are infections of the liver parenchyma, most often bacterial, occurring via the biliary tract, bloodstream, or by direct spread. Although rare, they are serious, with a mortality rate of around 15%. In Western countries, they are mainly polymicrobial or associated with Escherichia coli, streptococci, and Klebsiella pneumoniae. While overall incidence is low, it appears higher in Guadeloupe. There is a growing increase in cases caused by hypervirulent \*Klebsiella pneumoniae\* (hvKp), which can infect healthy individuals and spread to distant sites such as the eye, lungs, and central nervous system. Its virulence is linked to specific genetic factors. The emergence of multidrug-resistant hypervirulent strains represents a major concern. In Guadeloupe, about ten cases per year are reported, with no clearly identified risk factors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 22, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 15, 2024
CompletedFirst Submitted
Initial submission to the registry
February 10, 2025
CompletedFirst Posted
Study publicly available on registry
May 11, 2026
CompletedMay 11, 2026
May 1, 2026
2.9 years
February 10, 2025
May 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Microbial etiologies associated to pyogenic LA in Guadeloupe
Identification of bacteria responsible for pyogenic liver abscesses through culture (blood and/or pus), with analysis of their antibiotic susceptibility profile.
Baseline
Secondary Outcomes (10)
Clinical presentation of pyogenic LA
Baseline
Radiological characteristics of pyogenic liver abscess
At diagnosis (baseline)
Radiological features of pyogenic LA
Baseline
Risk factors associated with Klebsiella pneumoniae pyogenic liver abscess
Baseline
Virulence genes, antimicrobial resistance genes, and molecular typing of Klebsiella pneumoniae isolates
Baseline
- +5 more secondary outcomes
Study Arms (1)
Pyogenic liver abscess cohort
All patients diagnosed with pyogenic liver abscess managed at the participating center during the study period.
Eligibility Criteria
Prospective cohort of patients with liver abscesses in Guadeloupe
You may qualify if:
- Patients of 18 years old and older
- Radiological diagnosis of hepatic abscess
- Patients (a close relative if the patient is out of state to give his agreement )who have agreed to participate to the study
You may not qualify if:
- Patients under 18 years old
- Patient (a close relative if the patient is out of state to give his agreement ) who refuse to participate to the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chu de La Guadeloupe
Les Abymes, 97159, Guadeloupe
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Sébastien Breurec, MD PhD
CHU de la Guadeloupe
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 10, 2025
First Posted
May 11, 2026
Study Start
March 22, 2021
Primary Completion
February 15, 2024
Study Completion
February 15, 2024
Last Updated
May 11, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share